There currently is no effective therapy for coronary artery disease — a precursor to ischemia and myocardial infarction (heart attack) — but through her research, BIO5 member Shirin Doroudgar an assistant professor in the Department of Internal Medicine and a member of the Translational Cardiovascular Research Center at the University of Arizona College of Medicine – Phoenix, seeks to change that.